However, demyelinating conditions, including MS, rarely occur in RA patients who have not been treated with TNF-α inhibitors; also, the occurrence of extrapyramidal syndromes is low, but this could be attributed to anti-inflammatory drugs used as chronic treatment in RA. The gene discussed is TNF; the disease is myeloid sarcoma.